SG11201404413UA - A composition and use thereof in the treatment of anal rhagades - Google Patents

A composition and use thereof in the treatment of anal rhagades

Info

Publication number
SG11201404413UA
SG11201404413UA SG11201404413UA SG11201404413UA SG11201404413UA SG 11201404413U A SG11201404413U A SG 11201404413UA SG 11201404413U A SG11201404413U A SG 11201404413UA SG 11201404413U A SG11201404413U A SG 11201404413UA SG 11201404413U A SG11201404413U A SG 11201404413UA
Authority
SG
Singapore
Prior art keywords
treatment
composition
anal rhagades
rhagades
anal
Prior art date
Application number
SG11201404413UA
Inventor
Filippo Bastia
Maurizio Saccomanno
Original Assignee
Thd Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46001672&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SG11201404413U(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Thd Spa filed Critical Thd Spa
Publication of SG11201404413UA publication Critical patent/SG11201404413UA/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/168Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716Glucans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/01Hydrolysed proteins; Derivatives thereof
    • A61K38/011Hydrolysed proteins; Derivatives thereof from plants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0031Rectum, anus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/14Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
SG11201404413UA 2012-01-30 2012-01-30 A composition and use thereof in the treatment of anal rhagades SG11201404413UA (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IT2012/000027 WO2013114410A1 (en) 2012-01-30 2012-01-30 A composition and use thereof in the treatment of anal rhagades

Publications (1)

Publication Number Publication Date
SG11201404413UA true SG11201404413UA (en) 2014-10-30

Family

ID=46001672

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201404413UA SG11201404413UA (en) 2012-01-30 2012-01-30 A composition and use thereof in the treatment of anal rhagades

Country Status (24)

Country Link
US (1) US9345747B2 (en)
EP (1) EP2646039B1 (en)
JP (1) JP5903505B2 (en)
KR (1) KR101599447B1 (en)
CN (2) CN104114177A (en)
AU (1) AU2012368815B2 (en)
BR (1) BR112014018850A8 (en)
CA (1) CA2863369C (en)
DK (1) DK2646039T3 (en)
ES (1) ES2485490T3 (en)
HK (1) HK1186378A1 (en)
HR (1) HRP20140594T1 (en)
IL (1) IL233875A (en)
IN (1) IN2014MN01733A (en)
MX (1) MX336204B (en)
PL (1) PL2646039T3 (en)
RS (1) RS53457B (en)
RU (1) RU2580622C2 (en)
SA (1) SA113340239B1 (en)
SG (1) SG11201404413UA (en)
SI (1) SI2646039T1 (en)
TW (1) TWI495476B (en)
WO (1) WO2013114410A1 (en)
ZA (1) ZA201405208B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6523291B2 (en) 2013-12-24 2019-05-29 ザ プロクター アンド ギャンブル カンパニーThe Procter & Gamble Company Cosmetic composition and method for providing high penetration of skin care active ingredients
ITRM20150163A1 (en) * 2015-04-17 2016-10-17 Uniderm Farm S R L PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF ANAL RADIUS
US10117826B2 (en) 2016-03-31 2018-11-06 Peter Angia Pham Bodily lubricating and moisturizing compositions containing plant mucilage
US10835504B2 (en) 2018-04-18 2020-11-17 G&S Laboratories, Inc. Compositions to treat anal itch
WO2020022991A2 (en) * 2018-05-02 2020-01-30 Montero Gida Sanayi Ve Ticaret Anonim Sirketi Topical compositions for stretch marks on the skin
RU2771015C2 (en) * 2020-09-25 2022-04-25 Общество с ограниченной ответственностью "ФАРМКОММ" Pharmaceutical composition in the form of an ointment for the treatment of hemorrhoids

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5622939A (en) * 1992-08-21 1997-04-22 Alpha-Beta Technology, Inc. Glucan preparation
ATE214266T1 (en) * 1997-04-16 2002-03-15 Cognis France Sa USE OF A PROTEIN FRACTION EXTRACTED FROM HIBISCUS ESCULENTUS SEEDS IN COSMETICS
US6379719B1 (en) * 1998-04-08 2002-04-30 Laboratories Serobiologiques (Societe Anonyme) Use of at least one protein fraction extracted from Hibiscus esculentus seeds and cosmetic composition containing such a fraction
CN1233469A (en) * 1998-04-28 1999-11-03 王京杭 Tissue restoration accelerator
US6956120B2 (en) * 2000-11-09 2005-10-18 Yasushi Onaka β-1.3-1.6 glucan (Aureobasidium medium)
JP2002204687A (en) * 2000-11-09 2002-07-23 Onaka Yasushi APPLICATION OF beta-1,3-1,6-GLUCAN (AUREOBASIDIUM CULTURE SOLUTION) IN VARIOUS INDUSTRIAL FIELDS INCLUDING MEDICAL, HEALTH WELFARE AND FOOD INDUSTRIES
JP2003104832A (en) * 2001-09-28 2003-04-09 Chifure Keshohin:Kk Skin care preparation
JP4544500B2 (en) 2002-07-19 2010-09-15 一丸ファルコス株式会社 Hyaluronic acid synthesis accelerator
CA2523021C (en) * 2003-05-02 2013-06-11 Ceapro Inc. Improved extraction and purification method for cereal beta-glucan
RU2277920C2 (en) * 2004-02-24 2006-06-20 Государственное Учреждение "Пятигорский Государственный Научно-Исследовательский Институт Курортологии Министерства Здравоохранения Российской Федерации" Method for treating children in case of chronic viral hepatitis at applying sulfide baths and low-carbonate mineral water
ITMI20042111A1 (en) * 2004-11-04 2005-02-04 Biofarmitalia Spa PATCH CONTAINING A CHOSEN SUBSTANCE BETWEEN CATRAMS HAVING REDUCING CHARACTERISTICS IN DERMATOLOGY
JP5048935B2 (en) * 2005-08-24 2012-10-17 株式会社ヤクルト本社 Moisturizer
DE202007004856U1 (en) * 2007-04-01 2007-06-06 Rühle, Wilfried, Dipl.-Ing. Composition, useful to inhibit aging of skin, comprises chitin, beta-1,3/1,6D glucan and melanin complex; hyaluronic acid and myoxinol as active substance
CN101095482B (en) * 2007-07-05 2012-02-15 中国科学院长春应用化学研究所 Method for preparing barley wheat bran or oat wheat bran for the preparation of fibre foodstuff
US20090202664A1 (en) * 2008-02-11 2009-08-13 Svetislav Mikalacki Herbal cream or oil for the treatment hemorroids and wounds
ITUD20100112A1 (en) * 2010-06-09 2011-12-10 Farma Derma S R L PREPARATION FOR VAGINAL AND RECTAL USE AND ITS PRODUCTION PROCEDURE
CN102084963A (en) * 2010-09-29 2011-06-08 吉林省农业机械研究院 Method for preparing oat bran dietary fiber food

Also Published As

Publication number Publication date
CN104114177A (en) 2014-10-22
SA113340239B1 (en) 2015-07-07
HRP20140594T1 (en) 2014-10-24
BR112014018850A2 (en) 2017-06-20
IL233875A0 (en) 2014-09-30
RU2014129391A (en) 2016-03-27
TWI495476B (en) 2015-08-11
IL233875A (en) 2017-01-31
DK2646039T3 (en) 2014-08-11
HK1186378A1 (en) 2014-03-14
RS53457B (en) 2014-12-31
AU2012368815B2 (en) 2018-03-01
MX2014009244A (en) 2015-03-19
EP2646039A1 (en) 2013-10-09
MX336204B (en) 2016-01-11
JP2015504915A (en) 2015-02-16
IN2014MN01733A (en) 2015-07-10
KR101599447B1 (en) 2016-03-14
WO2013114410A1 (en) 2013-08-08
US20140303094A1 (en) 2014-10-09
CN109865000A (en) 2019-06-11
KR20140127296A (en) 2014-11-03
AU2012368815A1 (en) 2014-09-18
ES2485490T3 (en) 2014-08-13
ZA201405208B (en) 2015-10-28
CA2863369C (en) 2020-03-10
SI2646039T1 (en) 2014-10-30
RU2580622C2 (en) 2016-04-10
BR112014018850A8 (en) 2017-07-11
JP5903505B2 (en) 2016-04-13
CA2863369A1 (en) 2013-08-08
EP2646039B1 (en) 2014-05-14
US9345747B2 (en) 2016-05-24
PL2646039T3 (en) 2014-10-31
TW201334787A (en) 2013-09-01

Similar Documents

Publication Publication Date Title
HK1216176A1 (en) Unsymmetrical pyrrolobenzodiazepines-dimers for use in the treatment of proliferative and autoimmune diseases
IL236616B (en) 5-aminotetrahydroquinoline-2-carboxylic acids and use thereof
IL234628A0 (en) Amino-indolyl-substituted imidazolyl-pyrimidines and their use as medicaments
HK1203493A1 (en) Substituted azabicycles and use thereof
EP2927281A4 (en) Resin composition and use thereof
EP2828258A4 (en) Novelpyridopyrimidine derivatives and use thereof
GB201120993D0 (en) Novel compounds and their use in therapy
HK1214274A1 (en) Lipopetides for use in treating liver diseases and cardiovascular diseases
IL233875A0 (en) A composition and use thereof in the treatment of anal rhagades
EP2922536A4 (en) The use of bucillamine in the treatment of gout
HK1217688A1 (en) 6-chloro-3-(phenyl-d5)-inden-1-one and use thereof 6--3-(-d5)--1-
GB201222455D0 (en) Novel pharmaceutical formulations and their use in the treatment of periodontaldisease
HK1203198A1 (en) Substituted phenylimidazopyrazoles and use thereof
HK1209639A1 (en) Gpbp-1 inhibition and its therapeutic use gpbp-1
EP2817304A4 (en) Novel compounds and their use in therapy
EP2744786A4 (en) Substituted 2-imidazolidinones and 2-imidazolones and their use in the treatment of cancer
ZA201503266B (en) Pyidone derivatives and uses thereof in the treatment of tuberculosis
ZA201405910B (en) Use of modafinil in the treatment of cocaine addicts
ZA201408128B (en) Etract of greyia radlkoferi and use thereof
GB201308753D0 (en) Compounds and their use in therapy
PL2895751T3 (en) Screw and use thereof
HK1207154A1 (en) C1q-adiponectin complex and use thereof c1q-
LT2863932T (en) Composition for use in the treatment of lymphedema
ME03635B (en) 6-chloro-3-(phenyl-d5)-inden-1-one and use thereof
GB201308217D0 (en) Compounds and their use in therapy